Sign in
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022
Episode 17: 5-year Results of DRCR.net Protocol S: PRP laser vs Ranibizumab for PDR with Dr. Jennifer Sun
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Time to Dry Analysis of Brolucizumab Versus Aflibercept in Patients With Neovascular AMD: 96-Week Data From HAWK and HARRIER Trials
Carl D. Regillo, MD
Annual Meeting Talks
2019
Category: Pediatric Retina - ROP